Sonoma Pharmaceuticals

SNOA · NASDAQ

$1.15+$0.03 (+2.68%)TodayMarket closed ·
Prev close $1.12

Latest news

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

  • NewsVandana Singh

    Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

  • NewsVandana Singh

    What's Going On With Sonoma Pharma Stock Monday?

  • NewsAvi Kapoor

    Dow Falls Over 150 Points; Procter & Gamble Posts Upbeat Earnings

  • NewsAvi Kapoor

    Nasdaq Gains Over 100 Points; Intel Shares Jump After Strong Q1 Results

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • NewsMohd Haider

    Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

  • Press releaseACCESS Newswire

    National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

  • Press releaseACCESS Newswire

    Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Dow Falls Over 100 Points; Deere Shares Dip After Q3 Results

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    Market-Moving News for August 14th

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsAvi Kapoor

    Crude Oil Falls Over 3%; Philip Morris Earnings Top Views

  • NewsAvi Kapoor

    Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results

  • NewsRishabh Mishra

    US Stocks Likely To Open Higher After Trump Administration Hints At A Deal With China: 'It Is Prudent To Expect Continued Volatility In The Weeks Ahead,' Says Expert

  • NewsDylan Berman

    What's Going On With Sonoma Pharmaceuticals Stock Tuesday?

  • News

    Market-Moving News for March 11th

  • NewsHenry Khederian

    Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving

  • NewsAvi Kapoor

    Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

  • NewsAvi Kapoor

    Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.